Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$3.6 - $7.15 $61,185 - $121,521
16,996 New
16,996 $119,000
Q4 2022

Feb 14, 2023

BUY
$5.8 - $8.98 $137,199 - $212,421
23,655 New
23,655 $154,000
Q4 2019

Feb 14, 2020

SELL
$13.91 - $21.48 $169,702 - $262,056
-12,200 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$15.84 - $30.01 $193,248 - $366,122
12,200 New
12,200 $195,000

Others Institutions Holding MGTX

About MeiraGTx Holdings plc


  • Ticker MGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,010,700
  • Market Cap $292M
  • Description
  • MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative dise...
More about MGTX
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.